PARP inhibitory v léčbě karcinomu prsu u pacientek s BRCA mutací
| Title in English | PARP inhibitors in the treatment of breast cancer patients with BRCA mutations |
|---|---|
| Authors | |
| Year of publication | 2014 |
| Type | Article in Proceedings |
| Conference | Onkologická revue |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | hereditary breast cancer; BRCA1; BRCA2; PARP inhibitors |
| Description | Breast cancer is one of the most common malignant tumors in women, about 10 % of these tumours are represented by hereditary breast cancer, mainly due to mutations in BRCA1 a BRCA2 geenes. |